As of Feb 24
| +0.05 / +3.52%|
The 3 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 6.00 and a low estimate of 3.50. The median estimate represents a +172.11% increase from the last price of 1.47.
The current consensus among 7 polled investment analysts is to Hold stock in Arena Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.